194 related articles for article (PubMed ID: 36202619)
1. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
Reg Anesth Pain Med; 2023 Jan; 48(1):37-43. PubMed ID: 36202619
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada.
Allen ST; O'Rourke A; Johnson JA; Cheatom C; Zhang Y; Delise B; Watkins K; Reich K; Reich R; Lockett C
Ann Med; 2022 Dec; 54(1):2692-2700. PubMed ID: 36168975
[TBL] [Abstract][Full Text] [Related]
3. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
Reg Anesth Pain Med; 2024 May; 49(5):361-362. PubMed ID: 36427903
[No Abstract] [Full Text] [Related]
4. An exploratory study of a hands-on naloxone training for rural clinicians and staff.
Cody SL; Hines CB; Glenn CJ; Sharp-Marbury R; Newman S
J Nurs Scholarsh; 2023 May; 55(3):599-604. PubMed ID: 36411494
[TBL] [Abstract][Full Text] [Related]
5. Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study.
Khoury D; Preiss A; Geiger P; Anwar M; Conway KP
JMIR Public Health Surveill; 2021 May; 7(5):e29298. PubMed ID: 33999828
[TBL] [Abstract][Full Text] [Related]
6. A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic.
Zahan R; Osgood ND; Plouffe R; Orpana H
Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673354
[TBL] [Abstract][Full Text] [Related]
7. Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.
Grover JM; Alabdrabalnabi T; Patel MD; Bachman MW; Platts-Mills TF; Cabanas JG; Williams JG
Prehosp Emerg Care; 2018; 22(3):281-289. PubMed ID: 29297739
[TBL] [Abstract][Full Text] [Related]
8. Take-home Naloxone at Opioid Treatment Programs: A Lifesaver.
Katzman JG; Bhatt S; Comerci GD
J Addict Med; 2022 Nov-Dec 01; 16(6):619-621. PubMed ID: 35220332
[TBL] [Abstract][Full Text] [Related]
9. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
[TBL] [Abstract][Full Text] [Related]
11. CAEP Position Statement: Emergency department management of people with opioid use disorder.
Koh JJ; Klaiman M; Miles I; Cook J; Kumar T; Sheikh H; Dong K; Orkin AM; Ali S; Shouldice E
CJEM; 2020 Nov; 22(6):768-771. PubMed ID: 33028446
[TBL] [Abstract][Full Text] [Related]
12. The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for Patients at Risk for Opioid Overdose.
Benzon HT; Sun EC; Chou R
Anesth Analg; 2022 Jul; 135(1):21-25. PubMed ID: 35709441
[No Abstract] [Full Text] [Related]
13. Attitude changes following short-form opioid overdose video education: a pilot study.
Galiher MV; Huffman M
Harm Reduct J; 2022 Oct; 19(1):114. PubMed ID: 36241995
[TBL] [Abstract][Full Text] [Related]
14. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
15. Legal requirements and recommendations to prescribe naloxone.
Haffajee RL; Cherney S; Smart R
Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
[TBL] [Abstract][Full Text] [Related]
16. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
[No Abstract] [Full Text] [Related]
17. Controversies and carfentanil: We have much to learn about the present state of opioid poisoning.
Cole JB; Nelson LS
Am J Emerg Med; 2017 Nov; 35(11):1743-1745. PubMed ID: 28851500
[No Abstract] [Full Text] [Related]
18. Risks of opioid overdose among New York State Medicaid recipients with chronic pain before and during the COVID-19 pandemic.
Mannes ZL; Wheeler-Martin K; Terlizzi K; Hasin DS; Perry A; Pamplin JR; Crystal S; Cerdá M; Martins SS
Prev Med; 2023 Dec; 177():107789. PubMed ID: 38016582
[TBL] [Abstract][Full Text] [Related]
19. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
[TBL] [Abstract][Full Text] [Related]
20. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
